Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders Gallery

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B Gallery

Vivo Capital’s Portfolio Company, Preventice was Bought by Boston Scientific for $1.2B

Vivo Capital Appoints New Managing Partners and Partners Gallery

Vivo Capital Appoints New Managing Partners and Partners

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China Gallery

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

Serán Bioscience Announces Investment by Vivo Capital Gallery

Serán Bioscience Announces Investment by Vivo Capital

Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D Gallery

Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D

维梧资本完成第九期基金募集，14.3亿美元用于投资医疗健康和生命科学公司 Gallery

维梧资本完成第九期基金募集，14.3亿美元用于投资医疗健康和生命科学公司

Swift Health Systems Raises $45 Million in Series C Funding Gallery

Swift Health Systems Raises $45 Million in Series C Funding

Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare Gallery

Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare

Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities Gallery

Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities

维梧资本机会基金获超额认购，完成6.35亿美元融资 Gallery

维梧资本机会基金获超额认购，完成6.35亿美元融资

诺诚健华研发平台受青睐，维梧资本领投5500万美元融资 Gallery

诺诚健华研发平台受青睐，维梧资本领投5500万美元融资

维梧资本领投欧米尼医药C轮融资 升级版桥梁策略首试新药研发市场 Gallery

维梧资本领投欧米尼医药C轮融资 升级版桥梁策略首试新药研发市场

助力南京健友成功上市 维梧资本“桥梁战略”全面升级 Gallery

助力南京健友成功上市 维梧资本“桥梁战略”全面升级

Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million Gallery

Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million

维梧资本设立前期创投基金，首期募集资金超过一亿美元 Gallery

维梧资本设立前期创投基金，首期募集资金超过一亿美元

维梧资本公开认购巨星国际股份 助力企业进军医疗耗材领域 Gallery

维梧资本公开认购巨星国际股份 助力企业进军医疗耗材领域

维梧资本领投更美 APP 抢滩国内移动医疗领域 Gallery

维梧资本领投更美 APP 抢滩国内移动医疗领域

维梧低调支持长春长生资产交易 资本市场前景看好 Gallery

维梧低调支持长春长生资产交易 资本市场前景看好

成功助推海利生物上市 维梧资本大健康投资布局渐清晰 Gallery

成功助推海利生物上市 维梧资本大健康投资布局渐清晰

维梧资本第八期7.5亿美元募资超额完成 Gallery

维梧资本第八期7.5亿美元募资超额完成

Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China Gallery

Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China

Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China Gallery

Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China